Skip to main content
SpringerLink
Log in

Cabergoline warranted for PD in Germany vs levodopa

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cabergoline warranted for PD in Germany vs levodopa. Inpharma Wkly. 1402, 4 (2003). https://doi.org/10.2165/00128413-200314020-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200314020-00008

Keywords

Search

Navigation